Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
The British Journal of Psychiatry : the Journal of Mental Science|August 15, 2020
Effects of genomic copy number variants penetrant for schizophrenia on cortical thickness and surface area in healthy individuals: analysis of the UK BiobankXavier Caseras, George Kirov, Kimberley M Kendall, et al.
Neuro-Oncology|September 22, 2018
Uncommon low-grade brain tumorsThankamma Ajithkumar, Naduni Imbulgoda, Elliott Rees, et al.
Molecular Psychiatry|March 14, 2023
Family-based analysis of the contribution of rare and common genetic variants to school performance in schizophreniaAlexandros Rammos, George Kirov, Leon Hubbard, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 25, 2018
SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical PracticeJohn Wilding, Kevin Fernando, Nicola Milne, et al.
Translational Psychiatry|May 14, 2020
A brief report: de novo copy number variants in children with attention deficit hyperactivity disorderJoanna Martin, Grace Hosking, Megan Wadon, et al.
Schizophrenia Research|July 2, 2022
Machine learning for prediction of schizophrenia using genetic and demographic factors in the UK biobankMatthew Bracher-Smith, Elliott Rees, Georgina Menzies, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 11, 2019
SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into PracticeAmar Ali, Steve Bain, Debbie Hicks, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 20, 2019
Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into PracticeAmar Ali, Steve Bain, Debbie Hicks, et al.
BMC Genomics|December 5, 2018
Effects of pathogenic CNVs on physical traits in participants of the UK BiobankDavid Owen, Mathew Bracher-Smith, Kimberley M Kendall, et al.
Pageof 9